This trial is enrolling by invitation!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Tympanic Membrane Perforation
and you are
over 3
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The trial seeks to provide evidence that the Skye ActiveBarrier provides similar surgical and functional outcomes as fascia when used for tympanoplasties while offering benefits including reduced operative time, better patient satisfaction, and fewer complications.

Provided treatments

  • Other: Skye Barrier
  • Other: Fascia
Tris trial is registered with FDA with number: NCT03028272. The sponsor of the trial is University of Missouri-Columbia and it is looking for 50 volunteers for the current phase.
Official trial title:
Hearing Results and Post Surgical Outcomes Using Amniotic Membrane Allograft Versus Fascia for Tympanoplasty: A Randomized Prospective Trial